The rest of the world has not been out snoozing in the sun. But Americans have had access only to older generations of sunscreens that prevent sunburn—but not the deeper damage that can cause skin cancer.
While an investigation is underway into the exact nature of the problem, so far the likeliest explanation is that improper use of vaping devices has led to illness, or the death, of some users. But that sort of nuance isn't governing the thinking of the FDA or CDC officials, both of which are allowing myths and fearmongering to drive their policies and public statements.
What's an "Impossible Burger" you ask? Among other things, it contains soy protein, sunflower oil and a plant-based binder that produces the right mouth/feel properties. But, no sooner than the FDA finally approved this creation for sale, the nutrition police are now saying that it just isn't healthy enough -- and that it may possibly harm us. Give us a break.
The Trump Administration recently issued two executive orders relating to biomedical science. The first involved the regulation of biotechnology products; the second involved transparency in healthcare costs. We believe both are a step in the right direction.
Recently, the FDA met to discuss CBD, the non-psychoactive component of marijuana. It made us realize that we'd never really considered the definition of a drug. Any process involving lawyers hinges on the meaning of words, so what actually does the FDA regulate?
Dr. Henry Miller, a former FDA deputy commissioner, used to be a big fan of the New York Times' coverage of science and medicine. But no longer. He takes issue with an editorial that accuses the agency of reducing its scrutiny of new drugs. Dr. Miller explains why the Times is off-base: the development of precision medicine.
The FDA is supposed to regulate absence claims. But when it comes to GMO absence claims, the FDA has done absolutely nothing. That may be about to change.
Honey doesn't treat erectile dysfunction. If it does, it might be spiked with Viagra.
These smaller population “Orphan Diseases,” defined as those that affect less than 200,000 people across the U.S., collectively impact 25 million Americans. This substantial public health issue warrants Lancet's call-to-action.
The FDA has recalled medicine used to control blood pressure because it contains contaminants that might be carcinogenic. In the quest for more profit, a Chinese manufacturer broke the rules, thinking the ends justified the means.
The FDA's current regulatory framework is out of whack -- and it comes at the expense of patient safety. The Wild West of "stem cell" clinics continues. This time, patients are hospitalized with blood infections to spinal abscesses.